GKA — Abnormal Hemoglobin Quantitation Class II

FDA Device Classification

FDA product code GKA covers "Abnormal Hemoglobin Quantitation", a Class II medical device regulated under 21 CFR 864.7415. Submissions are reviewed by the Hematology panel. At least 20 recent 510(k) clearances have been granted under this product code.

Classification details

Product Code
GKA
Device Class
Class II
Regulation Number
864.7415
Submission Type
510(k)
Review Panel
HE
Medical Specialty
Hematology
Implant
No

Recent 510(k) clearances

K-NumberApplicantDevice NameDate
K232027SebiaCAPI 3 NEONAT Hb, CAPILLARYS 3 DBS InstrumentApr 4, 2024
K222635Trinity Biotech (Primus Corporation, Dba Trinity Biotech)Premier Resolution SystemAug 4, 2023
K192931Helena LaboratoriesV8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo ControlApr 19, 2022
K180762SebiaCAPI 3 HEMOGLOBIN(E)Dec 14, 2018
K171664Bio-Rad LaboratoriesHemoglobin Variants System on Newborn Hemoglobin System with GDM and HbReview…Sep 13, 2017
K112550SebiaCAPILLARYS HEMOGLOBIN, CAPILLARYS FLEX PIERCING SYSTEMMay 25, 2012
K112491SebiaSEBIA CAPILLARYS HEMOGLOBIN(E) WITH CAPILLARYS 2May 24, 2012
K091283SebiaCAPILLARYS NEONAT HB (PN 2006)Feb 22, 2010
K082227SebiaMINICAP HEMOGLOBIN(E) KIT, MODEL 2207, 2227Mar 26, 2009
K080911Bio-Rad Laboratories Inc., Clinical Systems DivisiVARIANT NBS SICKLE CELL PROGRAM REAGENT KIT, VARIANT NBS NEWBORN SCREENING…May 2, 2008
K052291SebiaCAPILLARY'S HEMOGLOBIN(E) (PN 2007)Jun 27, 2006
K050709WallacRESOLVE HEMOGLOBIN KIT, JB-2 STAINING SYSTEM, MODELS FR-9120, FR-9400, FR-9360…Mar 8, 2006
K051072Bio-Rad LaboratoriesBIO-RAD VARIANT NBS SICKLE CELL PROGRAMMay 12, 2005
K040146InterlabINTERLAB ACID HEMOGLOBIN ELECTROPHORESIS TEST SYSTEMMay 4, 2004
K955355Bio-RadVARIANT ALPHA-THALASSEMIA SHORT PROGRAMApr 26, 1996
K955283PrimusPRIMUS VARIANT SYSTEM PVS99Mar 1, 1996
K954048Bio-RadVARIANT HEMOGLOBINOPATHY PROGRAMNov 20, 1995
K924813Bio-RadVARIANT SICKLE CELL SHORT PROGRAMJan 14, 1993
K834595Beckman InstrumentsPARAGON ACID HEMOGLOBIN REAGENT KITMay 7, 1984
K840011IsolabRESOLVE-HBFeb 4, 1984

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.